News Madrigal Pharmaceuticals Appoints Bill Sibold as Chief Executive Officer Staff September 11, 2023 Iframe sync Post navigation Previous: Marker Therapeutics Announces Complete Response in First Lymphoma Patient Treated with MT-601 after CAR T RelapseNext: EyePoint Pharmaceuticals Reports Positive Masked Safety Update for Lead Product Candidate EYP-1901 in Ongoing PAVIA and DAVIO 2 Phase 2 Clinical Trials as of September 1, 2023 More Stories Healthcare News MindHYVE.ai™ and KPSIAJ Sign Strategic MOU to Advance AI-Driven Innovation in Education and Healthcare Across Karachi Staff December 23, 2025 Healthcare News Patient Care Pharmaceutical Castle Connolly Names Dr. Meegan Gruber, MD, PhD a 2026 Exceptional Woman in Medicine; Recognition to Be Featured in New York Magazine Staff December 23, 2025 Fitness Healthcare News Pharmaceutical Planning Time Off in 2026: Dr. Meegan Gruber, MD, PhD Releases a Recovery-Logistics Guide for Busy Professionals Considering Plastic Surgery Staff December 23, 2025
